-
MSF will keep operating in Gaza 'as long as we can': mission head
-
Russian Filippov wins first medal at Milan-Cortina Games for individual neutral athletes
-
Italian Milan takes sprint honours at UAE Tour
-
Dozens killed in jihadist attacks in northwest Nigeria
-
Zimbabwe unbeaten in T20 World Cup after six-wicket Sri Lanka win
-
Postecoglou admits taking Nottingham Forest post a 'bad decision'
-
Switzerland's Fatton wins women's ski mountaineering sprint on Olympic debut
-
Kinghorn, Van der Merwe return for Scotland against Six Nations strugglers Wales
-
Repsol says could boost Venezuela oil output over 50% in 12 months
-
UN says Israeli actions raise 'ethnic cleansing' fears in West Bank, Gaza
-
Arteta tells faltering leaders Arsenal to harness Wolves 'pain' against Spurs
-
Crowley gets nod for Irish as Prendergast drops out
-
Unbeaten Swiss to meet Great Britain in Olympic men's curling semis
-
UK police arrest ex-prince Andrew on suspicion of misconduct
-
Oil extends gains on US-Iran tensions, Europe stocks slide
-
Former prince Andrew, a historic downfall
-
Sri Lanka post 178-7 against Zimbabwe ahead of T20 Super Eights
-
OpenAI's Altman tells leaders regulation 'urgently' needed
-
US renews threat to leave IEA
-
Liverpool boss Slot says Isak in 'final stages of rehab'
-
Airbus ready to build two new European fighter jets if 'customers' ask
-
UN Sudan probe finds 'hallmarks of genocide' in El-Fasher
-
Costelow starts, Hamer-Webb makes Wales debut in Six Nations clash with Scotland
-
Facing US warnings, Iran defends right to nuclear enrichment
-
Ex-South Korea leader Yoon gets life in prison for insurrection
-
OpenAI's Altman says at India summit regulation 'urgently' needed
-
British couple held in Iran sentenced to 10 years
-
West Indies ease past Italy to tune up for T20 Super Eights
-
At least 16 killed after building collapses in Pakistan following blast
-
Summit photo op fails to unite AI startup rivals
-
OpenAI's Altman says world 'urgently' needs AI regulation
-
Horror comics boom in our age of anxiety
-
Turkey fires up coal pollution even as it hosts COP31
-
London fashion week opens with tribute to one of its greats
-
Ex-S.Korea leader Yoon gets life in prison for insurrection
-
Pea soup, veggie mash contest warms up Dutch winter
-
South Korea's Yoon: from rising star to jailed ex-president
-
Private companies seek to import fuel amid Cuban energy crisis
-
India search for 'perfect game' as South Africa loom in Super Eights
-
India's Modi calls for inclusive tech at AI summit
-
Airbus planning record commercial aircraft deliveries in 2026
-
Elections under fire: Colombia endures deadliest campaign in decades
-
Traore backs 'hungry' Italy against France in Six Nations
-
All-rounder Curran brings stuttering England to life at the death
-
South Korea court weighs death sentence for ex-president Yoon
-
Tech chiefs address India AI summit as Gates cancels
-
Australia rejects foreign threats after claim of China interference
-
Somali militias terrorise locals after driving out Al-Qaeda
-
Peru picks Balcazar as interim president, eighth leader in a decade
-
Australian defence firm helps Ukraine zap Russian drones
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN